Back
Astria Therapeutics Stock Price Chart
The dark truth about AI
Click here to learn more...
Sell
25
ATXS
Astria Therapeutics
Last Price:
9.52
Seasonality Move:
20.78%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATXS is experiencing slight selling pressure.
Astria Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.04 | Sell |
| 20-day SMA: | 9.95 | Sell |
| 50-day SMA: | 10.84 | Sell |
| 200-day SMA: | 11.01 | Sell |
| 8-day EMA: | 9.99 | Sell |
| 20-day EMA: | 10.19 | Sell |
| 50-day EMA: | 10.6 | Sell |
| 200-day EMA: | 10.62 | Sell |
Astria Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 40.36 | Sell |
| Chaikin Money Flow: | -71926 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.51 - 10.85) | Sell |
| Bollinger Bands (100): | (10.22 - 11.92) | Sell |
Astria Therapeutics Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Astria Therapeutics Stock
Is Astria Therapeutics Stock a Buy?
- Astria Therapeutics share price is 9.52 while ATXS 8-day simple moving average is 10.04, which is a Sell signal.
- The stock price of ATXS is 9.52 while Astria Therapeutics 20-day SMA is 9.95, which makes it a Sell.
- Astria Therapeutics 50-day simple moving average is 10.84 while ATXS share price is 9.52, making it a Sell technically.
- ATXS stock price is 9.52 and Astria Therapeutics 200-day simple moving average is 11.01, creating a Sell signal.
ATXS Technical Analysis vs Fundamental Analysis
Sell
25
Astria Therapeutics (ATXS)
is a Sell
Is Astria Therapeutics a Buy or a Sell?
-
Astria Therapeutics stock is rated a Sell
The current Astria Therapeutics [ATXS] share price is $9.52. The Score for ATXS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Astria Therapeutics Stock Info
Market Cap:
537.25M
Price in USD:
9.52
Share Volume:
195.23K
Astria Therapeutics 52-Week Range
52-Week High:
16.90
52-Week Low:
5.84
Sell
25
Astria Therapeutics (ATXS)
is a Sell
Astria Therapeutics Share Price Forecast
-
What is the Astria Therapeutics stock price today?
The Astria Therapeutics stock price is 9.52 USD today. -
Will ATXS stock go up or go down?
Astria Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Astria Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Astria Therapeutics is overvalued.
Is Astria Therapeutics Stock a Buy?
- Astria Therapeutics share price is 9.52 while ATXS 8-day exponential moving average is 9.99, which is a Sell signal.
- The stock price of ATXS is 9.52 while Astria Therapeutics 20-day EMA is 10.19, which makes it a Sell.
- Astria Therapeutics 50-day exponential moving average is 10.60 while ATXS share price is 9.52, making it a Sell technically.
- ATXS stock price is 9.52 and Astria Therapeutics 200-day simple moving average is 10.62, creating a Sell signal.
Fundamental Analysis of Astria Therapeutics
Is Astria Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.60 per share, and an increase next year of $0.10 per share.
Technical Analysis of Astria Therapeutics
Should I short Astria Therapeutics stock?
- ATXS Moving Average Covergence Divergence (MACD) indicator is -0.25, suggesting Astria Therapeutics is a Sell
- Astria Therapeutics Relative Strength Index (RSI) is 40.36, which suggest Astria Therapeutics is oversold
- The Bollinger Bands (25) for Astria Therapeutics is (9.51 - 10.85), which suggest Astria Therapeutics is a Sell
- The Bollinger Bands (100) for Astria Therapeutics is (10.22 - 11.92), which suggest Astria Therapeutics is a Sell
* Astria Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.